CCL18 and breast carcinoma: Testing this type of NP at various dimensions, the group demonstrated that the largest NPs (180 nm) delivered siRNA and induced CCL18 silencing in TAMs with higher efficacy than the other sizes, leading to substantial inhibition of breast cancer cell migration [127].